Form 4: RxSight Executive Ilya Goldshleger Executes Stock Options and Sells Shares Under 10b5-1 Plan

Ilya Goldshleger, Co-President and COO of RxSight, Inc., exercised stock options and sold shares of common stock under a pre-arranged Rule 10b5-1 trading plan.

Summary

• On October 10, 2024, Ilya Goldshleger exercised options to acquire 3,105 shares of RxSight common stock at a price of $15.08 per share and sold the same amount at a weighted average price of $48.8231.
• On October 11, 2024, Goldshleger exercised options to acquire 3,100 shares of RxSight common stock at a price of $15.08 per share and sold the same amount at a weighted average price of $50.1915.
• On October 14, 2024, Goldshleger exercised options to acquire 3,100 shares of RxSight common stock at a price of $15.08 per share and sold the same amount at a weighted average price of $50.0865.
• These transactions were executed under a Rule 10b5-1 trading plan adopted on June 3, 2024.
• Following these transactions, Goldshleger directly owns 42,246 shares of common stock and indirectly owns 1,372 shares through a spouse.
• He also holds options to purchase 84,197 shares of common stock.

Sentiment

Score: 5

Explanation: The sentiment is neutral as the document primarily reports stock transactions under a pre-arranged plan. It doesn't inherently indicate positive or negative sentiment about the company's performance.

Positives

• The executive's transactions are being conducted under a pre-arranged 10b5-1 trading plan, which can reassure investors that the sales are not based on insider information.

Industry Context

Executive stock transactions are a common occurrence in publicly traded companies. Monitoring these transactions can provide insights into management's perspective on the company's value and future prospects. The use of a 10b5-1 plan is a standard practice to avoid insider trading concerns.

Comparison to Industry Standards

• Executive compensation practices, including stock options and sales, are common across the industry.
• Companies like Alcon, Johnson & Johnson (Vision), and Bausch + Lomb also utilize stock-based compensation as part of their executive pay packages.
• The vesting schedules and exercise prices are generally aligned with industry norms to incentivize long-term performance.

Stakeholder Impact

• The transactions may have a minor impact on shareholders due to the change in ownership, but the use of a 10b5-1 plan mitigates concerns about insider information.

Key Dates